Has Steven Witzel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $686 in general payments to Steven Witzel, MD across 9 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Steven Witzel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Steven Witzel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Steven Witzel, MD

Internal Medicine · Vernon Hills, ILNPI 1922064641

Payments from drug & device makers

$686in general payments, 2019–2025

Across 9 payments — averaging $76.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$212
Abbott$138
Amgen$118
Boehringer Ingelheim$113
Baxter Healthcare$61
Hologic Sales And Service, LLC$45

What the payments were for

Food & beverage$686100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	2	$212
Abbott	1	$138
Amgen	1	$118
Boehringer Ingelheim	1	$113
Baxter Healthcare	2	$61
Hologic Sales And Service, LLC	2	$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$686 in reported general payments places this provider in the 70th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois →

Medicare billing

Part B allowed, 2024

$134,389

Medicare patients

289

Services billed

1,851

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	55	$51,946
OzempicSemaglutide	21	$34,290
JanuviaSitagliptin Phosphate	15	$21,603
XareltoRivaroxaban	16	$17,397
Breo ElliptaFluticasone/Vilanterol	25	$13,191
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	17	$10,733
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	33	$4,442
Atorvastatin Calcium	367	$4,099
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	23	$3,086
Pantoprazole Sodium	141	$2,843
Allopurinol	28	$2,789
Celecoxib	29	$2,487
Valsartan	64	$2,197
Metoprolol Succinate	141	$2,179
Levothyroxine Sodium	152	$2,002

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Novo NordiskOzempic	$212	$34,29021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 5,182 internal medicine providers in Illinois.

Other internal medicine in Vernon Hills

Dennis LevinsonChicago$25.3M
Mary BrownRockford$16M
Andrew BartlettChampaign$4.1M
Danny SugimotoChicago$4M
Peter O DonnellChicago$3.9M
Daniel CatenacciChicago$3.5M
Jeffrey GeohasEvanston$2.3M
Patricia WalshChicago$2.1M
Merle DiamondChicago$1.7M
Yoko MomoyamaLombard$1.6M

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →